Lingshu Medical Technology

Lingshu Medical Technology, founded in 2020 by Fei-Yue Wang, is a company that specializes in artificial intelligence-based precision diagnosis and treatment for mental health disorders, particularly depression. The company leverages AI to develop digital assessment and intervention tools, aiming to provide objective and personalized mental healthcare solutions.

The core of their offering involves using multimodal data, such as voice, facial expressions, and text, to analyze a patient's emotional and cognitive state. This data is processed through proprietary algorithms to create a digital phenotype, which helps in the early screening, diagnosis, and continuous monitoring of depression. This approach moves beyond traditional subjective scales to offer a more data-driven and precise assessment. One of their key products is an AI-driven digital therapy platform that delivers personalized intervention programs, including cognitive behavioral therapy (CBT), to patients.

The business model appears to be B2B, targeting hospitals and other medical institutions. Lingshu Medical Technology collaborates with these partners to integrate its technology into their clinical workflows, providing tools for both diagnosis and treatment. The company has established partnerships with several top-tier hospitals in China, such as Xuanwu Hospital and Anding Hospital in Beijing.

Keywords: mental health AI, precision psychiatry, depression diagnosis, digital therapeutics, cognitive behavioral therapy, multimodal data analysis, clinical decision support, emotional computing, digital phenotyping, mental healthcare technology